← FDA Drug Approvals (Drugs@FDA)
AMPHOTERICIN B
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2025-06-30
Drug application
- FDA Application #
ANDA212967- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMPHOTERICIN B
- Generic name
- AMPHOTERICIN B LIPOSOME
- Active ingredients
- AMPHOTERICIN B
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- MYLAN LABS LTD
- Manufacturer
- Mylan Institutional LLC
- First approval
- 2025-06-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown